Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Zhonghe Gene logo — Innovative DNA Biosynthesis Technology Research and Developm...

Zhonghe Gene

Innovative DNA Biosynthesis Technology Research and Development for a Healthier Future

Founded 2022 Seed Biotechnology

General Information

Company Name Zhonghe Gene
Founded Year 2022
Industries Biotechnology
Funding Stage Seed
Social

Get notified when Zhonghe Gene moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Zhonghe Gene

Zhonghe Gene is a biotechnology startup that is dedicated to revolutionizing the health industry through innovative DNA biosynthesis technology research and development. Founded in 2022, the company has garnered significant attention for its pioneering work in gene technology. Their recent Seed Round investment on 22 February 2024 saw participation from prominent investors such as Lenovo Capital, Apricot Capital, and Haitang Fund. Being at the forefront of cutting-edge biotechnology, Zhonghe Gene is poised for remarkable growth and impact in the coming years. With a focus on improving healthcare outcomes and advancing the understanding of DNA, the company has positioned itself as a key player in shaping a healthier future.

Taxonomy: genetic engineering, DNA synthesis, biomedical technology, gene technology, innovation, future technology, health, biotech startup, medical research, biomedical engineering, gene sequencing, molecular biology

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 3
Investor Investor Investor
22 Feb 2024

Zhonghe Gene Alternatives & Competitors

Zhonghe Gene vs
Spotlight Therapeutics
Spotlight Therapeutics United States

Biotechnology company that develops biologics targeted to specific cell populations in gene editing

Series B
22 employees
Biotechnology, Health Care
Zhonghe Gene vs
Pencil Biosciences Limited
Pencil Biosciences Limited United Kingdom

Developing the Next Generation Gene Editing Technology

Seed
15 employees
Biotechnology, Health Care
Zhonghe Gene vs
Bitrobius Genetics
Bitrobius Genetics United Kingdom

Developing the Gentrafix platform technology to revolutionise gene therapy.

Series A
6 employees
Biotechnology, Health Care

FAQ About Zhonghe Gene

Innovative DNA Biosynthesis Technology Research and Development for a Healthier Future
Zhonghe Gene was founded in 2022.
Zhonghe Gene operates in the following industries: Biotechnology.
Zhonghe Gene has completed 1 funding round. The latest funding stage is Seed.
Top alternatives and competitors to Zhonghe Gene include Spotlight Therapeutics, Pencil Biosciences Limited, Bitrobius Genetics, GenEditBio Limited, Borea Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Zhonghe Gene and Spotlight Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Zhonghe Gene and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy